A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients

被引：0
|
作者：
Forlano, Roberta [1 ]
Mullish, Benjamin H. [1 ]
Blanco, Jesus Miguens [1 ]
Danckert, Nathan [1 ]
Thursz, Mark [1 ]
Manousou, Pinelopi [1 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-950
引用
收藏
页码：S540 / S540
页数：1
相关论文
共 50 条
  • [21] IDENTIFYING PATIENTS AT RISK FOR FIBROSIS IN A PRIMARY CARE NAFLD COHORT
    Schreiner, Andrew
    Livingston, Sherry
    Zhang, Jingwen
    Mauldin, Patrick
    Moran, William P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S149 - S150
  • [22] Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort
    Schreiner, Andrew D. D.
    Livingston, Sherry
    Zhang, Jingwen
    Gebregziabher, Mulugeta
    Marsden, Justin
    Koch, David G. G.
    Petz, Chelsey A. A.
    Durkalski-Mauldin, Valerie L. L.
    Mauldin, Patrick D. D.
    Moran, William P. P.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (01) : 89 - 96
  • [23] Clinical Model for NASH or Advanced Fibrosis in Patients With Diabetes and NAFLD
    Bazick, Jessica
    Donithan, Michele
    Neuschwander-Tetri, Brent A.
    Kleiner, David E.
    Brunt, Elizabeth
    Wilson, Laura
    Doo, Edward
    Lavine, Joel E.
    Loomba, Rohit
    GASTROENTEROLOGY, 2014, 146 (05) : S948 - S948
  • [24] Serum homocysteine concentration as a marker for advanced diabetic nephropathy in a cohort of elderly patients
    Xulei Zheng
    Qiaorui Liu
    Zhiwen Liu
    BMC Endocrine Disorders, 23
  • [25] Serum homocysteine concentration as a marker for advanced diabetic nephropathy in a cohort of elderly patients
    Zheng, Xulei
    Liu, Qiaorui
    Liu, Zhiwen
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [26] Screening for advanced liver fibrosis in overweight and obese patients with NAFLD
    Stefan, Norbert
    METABOLISM AND TARGET ORGAN DAMAGE, 2022, 2 (04):
  • [27] PERFORMANCE OF ENHANCED LIVER FIBROSIS (ELF) TEST TO PREDICT ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Younossi, Zobair M.
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Nader, Fatema
    Pham, Huong
    Afendy, Arian
    Cable, Rebecca
    Racila, Andrei
    Younoszai, Zahra
    Lam, Brian P.
    Golabi, Pegah
    Henry, Linda
    Stepanova, Maria
    HEPATOLOGY, 2020, 72 : 934A - 935A
  • [28] Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients
    Ito, Takanori
    Nguyen, Vy H.
    Tanaka, Taku
    Park, Huiyul
    Yeh, Ming-Lun
    Kawanaka, Miwa
    Arai, Taeang
    Atsukawa, Masanori
    Yoon, Eileen L.
    Tsai, Pei -Chien
    Toyoda, Hidenori
    Huang, Jee-Fu
    Henry, Linda
    Jun, Dae Won
    Yu, Ming -Lung
    Ishigami, Masatoshi
    Nguyen, Mindie H.
    Cheung, Ramsey C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1013 - +
  • [29] LIPOPROTEIN(A) LEVELS IN NAFLD PATIENTS: A NOVEL BIOMARKER TO PREDICT HEPATIC FIBROSIS
    Meroni, Marica
    Longo, Miriam
    Lombardi, Rosa
    Paolini, Erika
    Macchi, Chiara
    Corsini, Alberto
    Sirtori, Cesare
    Fracanzani, Anna Ludovica
    Ruscica, Massimiliano
    Dongiovanni, Paola
    HEPATOLOGY, 2021, 74 : 1114A - 1114A
  • [30] NAFLD-HCC is associated with female sex and lower rates of advanced fibrosis in a prospective cohort of HCC patients
    Gkouvatsos, Konstantinos
    Myers, Shuna
    Spahr, Laurent
    Giostra, Emiliano
    Usel, Massimo
    Bascaron, Marie-Eve
    Frossard, Jean-Louis
    Bouchardy, Christine
    Neyroud-Caspar, Isabelle
    Negro, Francesco
    Goossens, Nicolas
    SWISS MEDICAL WEEKLY, 2018, 148 : 3S - 3S
12345